Kyle Molina, PharmD

Scripps Health

Disclosure(s): Innoviva Speciality Therapeutics: Advisor/Consultant; Melinta: Advisor/Consultant, Grant/Research Support; Merck: Grant/Research Support; Shionogi: Advisor/Consultant

Poster(s):

• (P-887) Evaluation of ceftriaxone and cefotaxime as surrogate markers for oral second and third generation cephalosporins in Escherichia coli strains from blood
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT